Axsome Therapeutics, Inc. (AXSM)
182.94
-3.27
(-1.76%)
USD |
NASDAQ |
Feb 12, 16:00
183.70
+0.76
(+0.42%)
After-Hours: 07:40
Axsome Therapeutics Free Cash Flow : -101.39M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Corcept Therapeutics, Inc. | 162.57M |
| Gilead Sciences, Inc. | 10.02B |
| Vanda Pharmaceuticals, Inc. | -82.95M |
| ACADIA Pharmaceuticals, Inc. | 98.97M |
| Amicus Therapeutics, Inc. | 9.691M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 1.046M |
| Cash from Investing (Quarterly) | -0.058M |
| Cash from Financing (Quarterly) | 21.27M |
| Free Cash Flow Per Share (Quarterly) | 0.0198 |
| Free Cash Flow to Equity (Quarterly) | 5.778M |
| Free Cash Flow to Firm (Quarterly) | 4.363M |
| Free Cash Flow Yield | -1.13% |